wla(warner lambert) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bull-like who wrote (868)	9/30/1999 3:31:00 PM
From: Anthony Wong	Read Replies (1) of 942

RESEARCH ALERT-Schroders details drug coverage biz.yahoo.com Excerpts: NEW YORK, Sept 30 (Reuters) - Schroders Securities on Thursday gave details on its start of coverage of five pharmaceutical companies. -- It added to its recommended list Bristol-Myers Squibb Co. (NYSE:BMY - news), Pfizer Inc. (NYSE:PFE - news) and Warner-Lambert Co. (NYSE:WLA - news) at outperform significantly. Warner-Lambert: -- Set 12-month price target of $85. -- Said it expects Warner-Lambert to grow EPS at a compounded annual pace of 20 percent from 1998 to 2003. -- Said while it is quite dependent on single growth driver, Lipitor, associated risks with the drug are low. -- Agouron acquisition and Warner's own promising pipeline to add sources of growth.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next